Overview and major shareholders

e-therapeutics plc (AIM:ETX) is an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.  Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.

We use our highly productive drug Discovery Engine to develop our own IP-protected, preclinical drug discovery programmes which will be of interest to partners looking to acquire or in-license novel and differentiated assets. Because of our novel network-driven drug discovery ("NDD") approach, we believe there is potential to enter into several different types of collaborative partnerships with biotech, pharma and other technology companies to create sustainable mutual value.

Please see Significant shareholdings for our major shareholders.

In this section:

Share price information

Reports, results & presentations

AIM Rule 26

Shareholder information

Significant shareholdings

Regulatory announcements

Corporate governance

Events calendar


Document archive